Concepedia

Jean David Fumet

JD

Statistics

Publications

7

Citations

476

H-Index

7

Active since

2016

Affiliations

Centre Georges François Leclerc(Current)

Inserm

Genomic and Immunotherapy Medical Institute

Université de Bourgogne

CHU Dijon Bourgogne

Jean David Fumet is an author at Centre Georges François Leclerc specializing in oncology, medicine, and immunotherapy.

Publications per year

2016–2020

7

Publications

7

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination

M. Grapin, Corentin Richard, Emeric Limagne et al. · Journal for ImmunoTherapy of Cancer · 2019 · 210 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Antibiotic Use Does Not Appear to Influence Response to Nivolumab

Courèche Kaderbhaï, Corentin Richard, Jean David Fumet et al. · Anticancer Research · 2017 · 108 citations · Full text

Pharmacy, Oncology, Pharmacology +12

Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer

Jean David Fumet, Nicolás Isambert, Alice Hervieu et al. · ESMO Open · 2018 · 47 citations · Full text

Medicine, Immunology, Oncology +17

Implementation and use of whole exome sequencing for metastatic solid cancer

Manon Réda, Corentin Richard, Aurélie Bertaut et al. · EBioMedicine · 2020 · 46 citations · Full text

Medicine, Molecular Biology, Oncology +13

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Valentin Dérangère, Jean David Fumet, Romain Boidot et al. · Oncotarget · 2016 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 7